After Novo Nordisk breached not one, not two, but seven clauses of the code that regulates U.K. drugmakers, its U.K. general manager is stepping down as president of the industry's national ...
Five vital new appointments made to regulator’s insight, perspective and advice group Five vital new appointments made to regulator’s insight, perspective and advice group The Association of the ...
The more healthcare professionals (HCPs) know the pharma industry, the more they trust the pharma industry. That is the claim of U.K. pharma industry group ABPI, which reported another small uptick in ...
The Association of the British Pharmaceutical Industry (ABPI) has added five new patient organisation figures to its patient advisory council, set up to provide patient perspective on its ...
There are glimmers of a recovery in the UK’s clinical research sector, with an uptick in the number of new studies being started, according to a new report. The analysis, published by the Association ...
Elliot Dunster (pictured) will start in his new role as executive director of comms at the IFPMA in April. He will manage three members of staff and report to director-general Thomas Cueni. Dunster ...
Lowering the cost-effectiveness threshold currently used by the National Institute for Health and Clinical Excellence (NICE) to assess innovative new medicines "would deny thousands, if not millions, ...
GlaxoSmithKline Consumer Healthcare, Cephalon UK Ltd and ProStraken Group plc have been named and publicly shamed for breaching the Association of the British Pharmaceutical Industry's (ABPI) Code of ...
Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. Japanese drugmaker Astellas Pharma has said it “deeply regrets” safety failings that on Friday triggered a ...
Leaders of the Association of the British Pharmaceutical Industry (ABPI) say the UK Government must address rising clawback rates on drug sales if innovation and investment are to maintain the country ...
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness.
A couple of months ago I used this blog to talk about REACT trials. I told people how we should all be part of randomised controlled trials, testing currently available treatments so that doctors ...